The effect of Tenecteplase on intravenous thrombus and retinal blood flow in patients with branch retinal vein occlusion (BRVO).
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2017
At a glance
- Drugs Tenecteplase (Primary)
- Indications Branch retinal vein occlusion
- Focus Therapeutic Use
- Acronyms T-BRVO
- 08 Jun 2016 Status changed from not yet recruiting to recruiting.
- 18 Jun 2015 Planned initiation date changed from 1 Apr 2015 to 1 Jul 2015 as per Australian New Zealand Clinical Trials Registry record.
- 05 Mar 2015 New trial record